Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients

被引:30
作者
Pan, Xing-Xi [1 ]
Liu, Ya-Jie [2 ]
Yang, Wen [1 ]
Chen, Yong-Fa [1 ]
Tang, Wu-Bing [1 ]
Li, Chu-Rong [3 ]
机构
[1] Nanhai Hosp Affiliated So Med Univ, Dept Oncol, Foshan, Guangdong, Peoples R China
[2] Peking Univ Shenzhen Hosp, Dept Radiat Oncol, Shenzhen, Guangdong, Peoples R China
[3] Univ Elect Sci, Sichuan Canc Hosp,Res Inst,Sichuan Canc Ctr, Sch Med,Dept Radiat Oncol,Technol China, Chengdu, Sichuan, Peoples R China
关键词
Nasopharyngeal carcinoma; histological subtype; SEER; cause-specific survival; prognosis; CLASSIFICATION; UPDATE;
D O I
10.1002/lary.28099
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives There is currently no consensus on the prognostic significance of the histological subtype of nasopharyngeal carcinoma (NPC). The aim of the current study was to evaluate the impact of histological subtype on survival in NPC patients based on the Surveillance, Epidemiology, and End Results (SEER) Program. Methods Patients with NPC were identified within the SEER database (2004-2015). The effects of histological subtype on cause-specific survival (CSS) in NPC patients were evaluated using univariate and multivariate Cox regression analyses. Subgroup analysis according to histological subtype in NPC patients was carried out by 1:1 propensity score matching (PSM). Results A total of 4085 NPC patients were selected from the SEER database, including 1929 with keratinizing squamous cell carcinoma (KSCC), 2203 with nonkeratinizing carcinoma (NKC), and 53 with basaloid squamous cell carcinoma (BSCC). The 3-year and 5-year CSS rates were 61.76% and 55.07% for KSCC patients, 79.57% and 72.09% for NKC patients, and 77.55% and 74.03% for BSCC patients, respectively. Multivariate analysis identified sex, age, marital status, race, T stage, N stage, M stage, radiotherapy, chemotherapy, and histological subtype as significant prognostic factors for CSS in NPC patients. KSCC was found to be associated with worse CSS than NKC on Kaplan-Meier analysis and subgroup analysis after 1:1 PSM. Conclusions Histological subtype determines the long-term survival outcomes of patients with NPC. Moreover, the NKC subtype has the best prognosis, while the KSCC subtype has the worst prognosis. Level of Evidence NA Laryngoscope, 130:E83-E88, 2020
引用
收藏
页码:E83 / E88
页数:6
相关论文
共 23 条
[1]   Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study) [J].
Au, K. H. ;
Ngan, Roger K. C. ;
Ng, Alice W. Y. ;
Poon, Darren M. C. ;
Ng, W. T. ;
Yuen, K. T. ;
Lee, Victor H. F. ;
Tung, Stewart Y. ;
Chan, Anthony T. C. ;
Sze, Henry C. K. ;
Cheng, Ashley C. K. ;
Lee, Anne W. M. ;
Kwong, Dora L. W. ;
Tam, Anthony H. P. .
ORAL ONCOLOGY, 2018, 77 :16-21
[2]  
Burt RD, 2010, INT J CANCER, V52, P549
[3]  
Chan A T, 1998, Clin Oncol (R Coll Radiol), V10, P161, DOI 10.1016/S0936-6555(98)80057-5
[4]  
Chan JJC., 2005, WHO CLASSIFICATION T
[5]   Plasma EBV DNA as a Predictive Biomarker in Patients With Endemic Nasopharyngeal Carcinoma Treated With Induction Chemotherapy and Concurrent Chemoradiation Therapy [J].
Chua, M. ;
Sze, O. Whee ;
Wee, J. ;
Soong, Y. ;
Lim, D. ;
Tan, T. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 :S120-S121
[6]   Prognostic factors and outcome for nasopharyngeal carcinoma [J].
Farias, TP ;
Dias, FL ;
Lima, RA ;
Kligerman, J ;
de Sa, GM ;
Barbosa, MM ;
Goncalves, FB .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (07) :794-799
[7]   CANCER OF THE NASOPHARYNX IN BRITISH-COLUMBIA [J].
FLORES, AD ;
DICKSON, RI ;
RIDING, K ;
COY, P .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (04) :281-291
[8]   Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area [J].
Garcia-Lorenzo, J. ;
Farre, N. ;
Codina, A. ;
Gallego, O. ;
De Vega, M. ;
Leon, X. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (06) :777-783
[9]   Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis [J].
Huang, Xiao-Dan ;
Zhou, Guan-Qun ;
Lv, Jia-Wei ;
Zhou, Hua-Qiang ;
Zhong, Chen-Wen ;
Wu, Chen-Fei ;
Zheng, Zi-Qi ;
He, Xiao-Jun ;
Peng, Liang ;
Ma, Jun ;
Sun, Ying .
RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) :389-395
[10]   Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin [J].
Lin, Shaojun ;
Pan, Jianji ;
Han, Lu ;
Guo, Qiaojuan ;
Hu, Cairong ;
Zong, Jingfeng ;
Zhang, Xiuchun ;
Lu, Jiade Jay .
RADIOTHERAPY AND ONCOLOGY, 2014, 110 (03) :385-389